Metabolomic and proteomic stratification of equine osteoarthritis.

Authors: Anderson James R, Phelan Marie M, Caamaño-Gutiérrez Eva, Clegg Peter D, Rubio-Martinez Luis M, Peffers Mandy J

Journal: Equine veterinary journal

DOI: 10.1111/evj.14490 PubMed: 39972657Log in to save

Summary

# Editorial Summary: Metabolomic and Proteomic Stratification of Equine Osteoarthritis Current clinical approaches to equine osteoarthritis rely heavily on physical examination and radiographic changes, which inherently detect disease only after substantial joint damage has already occurred—a significant limitation given that OA pathogenesis remains incompletely understood and no treatments offer disease reversal. Anderson and colleagues employed metabolomic and proteomic profiling to identify molecular signatures that correlate with OA severity, moving beyond conventional diagnostic paradigms towards a biological fingerprinting approach. By characterising differentially abundant metabolites and proteins across varying degrees of osteoarthritic change, the researchers have established biochemical markers that could enable earlier detection, allow more nuanced tracking of disease progression, and provide objective measures for evaluating treatment efficacy in ways radiography and clinical signs cannot. For farriers, veterinarians, physiotherapists and nutritionists, these findings offer potential tools for stratifying individual cases and personalising management strategies based on underlying pathological state rather than gross structural changes alone. The work represents an important step towards precision diagnosis and monitoring in equine orthopaedic practice, though translation of these molecular signatures into practical clinical applications will require validation and integration into routine diagnostic workflows.

Read the full abstract on PubMed

Practical Takeaways

•Blood or synovial fluid biomarkers may enable earlier OA detection than current clinical and radiographic methods, allowing intervention before advanced joint damage
•Metabolomic/proteomic profiling could help stratify OA severity and monitor treatment efficacy in clinical practice
•Identifying disease-specific molecular signatures may guide personalized treatment selection and improve outcomes in OA management

Key Findings

•Metabolomic and proteomic profiling can stratify equine osteoarthritis cases by severity
•Differentially abundant metabolites and proteins correlate with osteoarthritis progression
•Early biomarker identification may enable detection of OA before significant radiographic changes
•Multi-omics approach provides potential for tracking disease progression and treatment response

Conditions Studied

osteoarthritis

Related References

Relationship between synovial fluid levels of glycosaminoglycans, hydroxyproline and general MMP activity and the presence and severity of articular cartilage change on the proximal articular surface of P1.

van den Boom R, van der Harst M R, Brommer H, Brama P A J, Barneveld A, van Weeren P R, DeGroot J(2005)Equine veterinary journal

The horse as a model of naturally occurring osteoarthritis

McIlwraith C. W., Frisbie D. D., Kawcak C. E.(2012)Bone & Joint Research

Influence of repeated arthrocentesis and exercise on synovial fluid concentrations of nitric oxide, prostaglandin E2 and glycosaminoglycans in healthy equine joints.

van den Boom R, van de Lest C H A, Bull S, Brama R A J, van Weeren P R, Barneveld A(2005)Equine veterinary journal

Detection of experimental cartilage damage with acoustic emissions technique: An in vitro equine study.

Shakya B R, Tiulpin A, Saarakkala S, Turunen S, Thevenot J(2020)Equine veterinary journal

Equine osteoarthritis: a brief review of the disease and its causes

Schlueter Angela E, Orth Michael W(2004)Equine and Comparative Exercise Physiology